# Safety, Blood Levels and Effects of MGB-BP-3

> **NCT02518607** · PHASE1 · COMPLETED · sponsor: **MGB Biopharma Limited** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** MGB-BP-3
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02518607
- **Lead sponsor:** MGB Biopharma Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-03-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02518607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02518607, "Safety, Blood Levels and Effects of MGB-BP-3". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02518607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*